We are live on ! Find out more
AGA

Altrinsic Global Advisors Portfolio holdings

AUM $2.79B
1-Year Est. Return 7.25%
This Fund
S&P 500
This Quarter Est. Return
+11.04%
1 Year Est. Return
+7.25%
3 Year Est. Return
+44.27%
5 Year Est. Return
+55.25%
10 Year Est. Return
+173.46%
AUM
$2.17B
AUM Growth
+$80M
Cap. Flow
-$120M
Cap. Flow %
-5.55%
Top 10 Hldgs %
56.07%
Holding
84
New
2
Increased
40
Reduced
26
Closed
2

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$17.3M
2
CTSH icon
Cognizant
CTSH
+$12.5M
3
SLB icon
SLB Ltd
SLB
+$9.69M
4
VOD icon
Vodafone
VOD
+$8.86M
5
CHTR icon
Charter Communications
CHTR
+$8.16M

Top Sells

Rank Stock Value
1
IBN icon
ICICI Bank
IBN
+$41.5M
2
CHKP icon
Check Point Software Technologies
CHKP
+$28.4M
3
WTW icon
Willis Towers Watson
WTW
+$27.7M
4
AON icon
Aon
AON
+$24.5M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$18.7M

Sector Composition

Rank Sector Weight
1 Financials 29.87%
2 Communication Services 20.26%
3 Healthcare 12.89%
4 Technology 9.51%
5 Energy 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TS icon
51
Tenaris
TS
$28.9B
$2.5M 0.12%
88,494
– –
SNDA icon
52
Sonida Senior Living
SNDA
$1.91B
$2.34M 0.11%
39,067
+4,000
+11% +$362K
AAC
53
DELISTED
AAC Holdings
AAC
$2.16M 0.1%
1,174,370
– –
L icon
54
Loews
L
$23.9B
$2.08M 0.1%
43,472
+3,670
+9% +$173K
VIV icon
55
Telefônica Brasil
VIV
$20.6B
$2.02M 0.09%
167,587
-44,668
-21% -$564K
IBN icon
56
ICICI Bank
IBN
$108B
$2M 0.09%
174,568
-3,997,664
-96% -$41.5M
NUVA
57
DELISTED
NuVasive, Inc.
NUVA
$1.97M 0.09%
34,700
-5,300
-13% -$282K
NSTG
58
DELISTED
NanoString Technologies, Inc.
NSTG
$1.91M 0.09%
80,000
-235,111
-75% -$5.4M
NVRO
59
DELISTED
NEVRO CORP.
NVRO
$1.88M 0.09%
30,000
-5,000
-14% -$235K
SHG icon
60
Shinhan Financial Group
SHG
$32.8B
$1.77M 0.08%
47,773
+17,104
+56% +$642K
NTES icon
61
NetEase
NTES
$85.3B
$1.75M 0.08%
36,265
+17,930
+98% +$853K
KURA icon
62
Kura Oncology
KURA
$800M
$1.74M 0.08%
105,000
– –
EHC icon
63
Encompass Health
EHC
$11B
$1.63M 0.08%
34,996
+2,992
+9% +$152K
XENE icon
64
Xenon Pharmaceuticals
XENE
$6.06B
$1.63M 0.08%
160,000
+10,000
+7% +$84.8K
CSCO icon
65
Cisco
CSCO
$457B
$1.51M 0.07%
28,040
+2,380
+9% +$116K
DVCR
66
DELISTED
Diversicare Healthcare Services Inc
DVCR
$1.45M 0.07%
373,952
– –
AKCA
67
DELISTED
Akcea Therapeutics Inc
AKCA
$1.43M 0.07%
50,286
-25,000
-33% -$728K
CFMS
68
DELISTED
Conformis, Inc. Common Stock
CFMS
$1.38M 0.06%
19,158
+2,000
+12% +$57K
ARA
69
DELISTED
American Renal Associates Holdings, Inc
ARA
$1.35M 0.06%
220,000
+100,000
+83% +$1.16M
DRNA
70
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.32M 0.06%
+90,000
New +$1.03M
AGTC
71
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.29M 0.06%
306,900
+60,000
+24% +$210K
FATE icon
72
Fate Therapeutics
FATE
$286M
$1.23M 0.06%
70,000
– –
FPRX
73
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.21M 0.06%
90,000
– –
VIPS icon
74
Vipshop
VIPS
$7.37B
$1.01M 0.05%
125,615
– –
ELGX
75
DELISTED
Endologix Inc
ELGX
$859K 0.04%
130,000
+16,500
+15% +$109K
1 2
3
4

Similar funds

HP
Hosking Partners London, United Kingdom $2.79B AUM 58.33% 1-Year Est. Return
MC
Maplelane Capital New York $2.79B AUM 52.02% 1-Year Est. Return
HCC
Hill City Capital Boston, Massachusetts $2.8B AUM 79.27% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $2.8B AUM 65.68% 1-Year Est. Return
GI
GLOBALT Investments Atlanta, Georgia $2.8B AUM 21.13% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

Altrinsic Global Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Altrinsic Global Advisors held 84 positions worth $2.17B, up 3.8% from $2.09B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Altrinsic Global Advisors withdrew a net $120M in Q1 2019, closing 2 positions and reducing 26 holdings. Its most notable exit was ZTO Express, an estimated $682K position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 32% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Altrinsic Global Advisors opened a new position in Dicerna Pharmaceuticals, Inc. worth $1.32M.

  • Altrinsic Global Advisors's largest Q1 2019 buy was Dicerna Pharmaceuticals, Inc.: 90,000 shares worth $1.32M.
  • Altrinsic Global Advisors added most to Bristol-Myers Squibb in Q1 2019, an estimated $17.3M increase.
  • Altrinsic Global Advisors's biggest Q1 2019 reduction was ICICI Bank, cutting an estimated $41.5M.
  • Altrinsic Global Advisors fully exited ZTO Express in Q1 2019, selling an estimated $682K.
  • Altrinsic Global Advisors's ten largest holdings make up 56% of its $2.17B portfolio in Q1 2019.
  • Altrinsic Global Advisors opened 2 new positions and closed 2 in Q1 2019.
  • Altrinsic Global Advisors's portfolio value rose 3.8% quarter-over-quarter to $2.17B.

Based on Altrinsic Global Advisors's 13F filing for Q1 2019, filed 14 May 2019.